CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea · Delayed Price · Currency is KRW 1,165.00
+26.00 (2.28%)
At close: Sep 4, 2026
CG MedTech Market Cap
CG MedTech has a market cap or net worth of 120.3 billion as of September 4, 2026. Its market cap has increased by 14.44% in one year.
Market Cap
120.30B
Enterprise Value
130.24B
Revenue
51.20B
Ranking
n/a
PE Ratio
18.05
Stock Price
1,165.00
ChartMarket Cap Chart
Since November 12, 2015, CG MedTech's market cap has decreased from 171.35B to 120.30B, a decrease of -29.80%. That is a compound annual growth rate of -3.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 120.30B | -0.26% |
| Dec 30, 2025 | 120.61B | 15.87% |
| Dec 30, 2024 | 104.09B | 129.46% |
| Dec 30, 2021 | 45.36B | 26.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JW Shinyak | 191.64B |
| DuChemBIO | 175.66B |
| Sewoon Medical | 102.49B |
| OSTEONIC | 85.16B |
| SCL Science | 76.70B |
| KM Corporation | 41.87B |
| Wonbiogen | 41.31B |
| MEDYSSEY Co.,Ltd | 37.70B |